US 10017516
BMP inhibitors and methods of use thereof
granted A61PA61P1/16A61P11/00
Quick answer
US patent 10017516 (BMP inhibitors and methods of use thereof) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH
- Grant date
- Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/08, A61P13/12